Naiyer A Rizvi

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Topics

Epidermal Growth Factor Receptor

Monoclonal Antibody

Top Venues

Cancer immunology research

Clinical cancer research : an official journal of the American Association for Cancer Research

Science (New York, N.Y.)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research 11 (2) (2023)
Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research 11 (2) (2023)
Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research 11 (2) (2023)
Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-Cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research (2022)
Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Jeffrey S Wasser, Eric Angevin, Patrick A Ott, Alison Forgie, Wenjing Yang, Cen Guo, Jeffrey Chou, Anthony B El-Khoueiry
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors. Journal for immunotherapy of cancer 10 (10) (2022)
Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-Cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research (2022)
Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-Cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research (2022)
Rohan Maniar, Peter H Wang, Robert S Washburn, Radomir Kratchmarov, Shana M Coley, Anjali Saqi, Samuel S Pan, Jianhua Hu, Catherine A Shu, Naiyer A Rizvi, Brian S Henick, Steven L Reiner
Self-Renewing CD8+ T-Cell Abundance in Blood Associates with Response to Immunotherapy. Cancer immunology research (2022)
Bonnie S Glisson, Rom S Leidner, Robert L Ferris, John D Powderly, Naiyer A Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James P Ohr, Jennifer Burton, Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M Townsley, Sandip Pravin Patel
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Meagan Montesion, Karthikeyan Murugesan, Dexter X Jin, Radwa Sharaf, Nora Sanchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S Sokol, Dean C Pavlick, Jay A Moore, Alan Braly, Gaurav Singal, David Fabrizio, Leah A Comment, Naiyer A Rizvi, Brian M Alexander, Garrett M Frampton, Priti S Hegde, Lee A Albacker
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response. Cancer discovery 11 (2) (2020)
Han Si, Michael Kuziora, Katie J Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban Scheuring, Solange Peters, Naiyer A Rizvi, Philip Z Brohawn, Koustubh Ranade, Brandon W Higgs, Kimberly C Banks, Vikram K Chand, Rajiv Raja
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (6) (2020)
Ani S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, Aung Naing, Ashish V Chintakuntlawar, Naiyer A Rizvi, Helen J Ross, Michael Gordon, Philip R Mallinder, Nairouz Elgeioushi, Ignacio González-García, Nathan Standifer, Jennifer Cann, Nicholas Durham, Shahram Rahimian, Rakesh Kumar, Crystal S Denlinger
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Diego Chowell, Luc G T Morris, Claud M Grigg, Jeffrey K Weber, Robert M Samstein, Vladimir Makarov, Fengshen Kuo, Sviatoslav M Kendall, David Requena, Nadeem Riaz, Benjamin Greenbaum, James Carroll, Edward Garon, David M Hyman, Ahmet Zehir, David B Solit, Michael F Berger, Ruhong Zhou, Naiyer A Rizvi, Timothy A Chan
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science (New York, N.Y.) 359 (6375) (2017)